The quality of laryngoscopy and tracheal intubation with propofol augmented by alfentanil was investigated as an alternative technique for rapid tracheal intubation. 119 patients aged between 18 and 60 years (ASA 1 and 2) undergoing elective surgery were prospectively studied in a randomized double-blind controlled fashion. Tracheal intubation facilitated by suxamethonium 1.0 mg/kg, alfentanil 15 µg/kg, alfentanil 30 µg/kg or saline control was compared after propofol induction. The quality of laryngoscopy and intubation were graded according to jaw relaxation, ease of insertion of the endotracheal tube and coughing on intubation. Failure to intubate occurred in 4% and 17% with alfentanil 15 µg/kg and saline control respectively. Tracheal intubation was successful in all patients with alfentanil 30 µg/kg and suxamethonium 1.0 mg/kg. Alfentanil 15 µg/kg was not statistically significantly different from saline (P = 0.112). Alfentanil 30 µg/kg provided similar overall intubating conditions (P = 0.5) to suxamethonium 1.0 mg/kg. Alfentanil in both dosages effectively attenuated the haemodynamic responses to laryngoscopy and tracheal intubation.
A rapid sequence induction technique allows the airway to be secured quickly by endotracheal intubation to prevent aspiration of gastric contents. Easy and uneventful rapid sequence induction tracheal intubation depends on the technical skill of the anaesthesia provider, depth of anaesthesia, neurovegetative stability, degree of airway relaxation and a suitable length of apnoea 1 . Routinely, this is facilitated by a rapidly acting muscle relaxant after an intravenous anaesthetic agent. Although suxamethonium is the muscle relaxation of choice, situations are often encountered when its use is absolutely contraindicated 2 or undesirable.
Propofol, an intravenous anaesthetic agent used for both induction and maintenance of anaesthesia, is known to decrease pharyngeal and laryngeal reactivity and muscle tone 3 . It has even been suggested that tracheal intubation may be carried out after propofol alone 4, 5 . However, this has been reported as very unsatisfactory 6, 7 . If anaesthesia is deepened either by administering additional doses of the induc-tion agent, or by opioids, perhaps the intubating conditions may be improved.
Alfentanil 8 , a synthetic opioid, has many desirable features to perform such a task. In contrast to other opioids, it has a rapid onset of action in approximately one minute. Its antitussive properties and its ability to produce profound apnoea would provide favourable conditions for intubation. Furthermore, based on its pharmacokinetic profile, alfentanil has a very short duration of action.
Recent work has shown that propofol augmented by alfentanil provided good laryngoscopy and intubating conditions without muscle relaxants in elective patients [9] [10] [11] [12] [13] [14] . However, a fixed dose of propofol was often used and not titrated to the same end-point. Furthermore, time to laryngoscopy was variable and positive pressure ventilation before intubation was occasionally employed. The aim of this study was therefore to investigate the quality of tracheal intubation after a simulated rapid sequence induction with propofol and alfentanil.
PATIENTS AND METHODS
This study was approved by the local ethics scientific committee and informed consent was obtained from each patient. One hundred and twenty healthy patients scheduled for elective surgery were prospectively studied. Only patients aged between 18 and 60 years, and of ASA 1 and 2 were included in the study. Patients with known or anticipated difficult intubation, aspiration risk, or patients undergoing head and neck surgery or those presenting with an absolute contraindication to the use of suxamethonium were excluded.
The study was conducted in a randomized doubleblind controlled fashion. Patients were allocated into one of four groups: Group PO received only propofol: Group PA15, propofol and alfentanil 15 µg/kg; Group PA30, propofol and alfentanil 30 µg/kg; and Group PS, propofol and suxamethonium 1.0 mg/kg.
All patients received midazolam 7.5 mg, given orally an hour before the anticipated surgery. Blood pressure was monitored non-invasively with an automated blood pressure monitor set at one-minute intervals (Critikon, DINAMAP® 8100). A total of six readings were obtained, i.e. preinduction, postinduction, postintubation, and at one, two and three minutes postintubation. Arterial oxygen saturation was measured by pulse oximetry (Nellcor), end-tidal carbon dioxide with a capnograph, and electrocardiography was also monitored. After insertion of the IV cannula under local anaesthesia into a forearm vein, preoxygenation was performed for three minutes using a fitting mask attached to a circle circuit with an oxygen flow of 8 litres/min. Patients in the alfentanil groups (Groups PA15 and PA30) received the corresponding alfentanil dose (prepared in 10 ml) over 30 seconds followed by propofol which was titrated at a rate of about 200 mg/min until loss of verbal response, after which 10 ml of 0.9% saline was given. Patients in the other two groups (Group PS and PO) received instead, 10 ml of 0.9% saline followed by propofol in the same fashion, after which suxamethonium (diluted in 10 ml) or 0.9% saline was given. The drugs were given by an anaesthetic trainee who was unaware of the drugs before its administration. Cricoid pressure was applied following loss of verbal response and no positive pressure ventilation was performed before intubation.
A regular anaesthetist (GST) who was unaware of the randomization process entered the operating room 30 seconds after completion of drug administration to perform direct laryngoscopy and orotracheal intubation. She did not witness the injection of the drugs nor the presence of any fasciculations and was unaware of the induction sequence or technique.
The quality of intubation was graded using a scoring system devised by Saarnivaara and Klemola 13 ( Table 1) . Intubating conditions were assessed as good (total score [TS] = 5-6), moderate (TS = 3-4), poor (TS = 1-2) or impossible, on the basis of jaw relaxation (0 = no relaxation; 1 = moderate relaxation, 2 = complete relaxation), ease of insertion of the endotracheal tube (ETT) (0 = vigorous movement of the vocal cords and impossible to insert the tube, 1= slight movements of the cords, 2 = relaxed vocal cords without any movement), and coughing on intubation (0 = vigorous coughing, 1 = slight coughing, 2 = no coughing). If intubation was unsuccessful after the first attempt, suxamethonium 1.0 mg/kg was given as a rescue in the appropriate groups. Blood pressure and heart rate data of the patients who needed suxamethonium rescue were excluded from the results. After intubation, the patient's lungs were ventilated with 66% nitrous oxide in oxygen maintaining normocapnia. After confirming correct positioning of the endotracheal tube, vecuronium 0.1 mg/kg was given. Volatile anaesthetics and further opioids were only given after the required number of blood pressure and heart rate readings were recorded. The study then ended at this point and anaesthesia continued according to the corresponding consultant anaesthetist's preferences.
Statistics
The Chi-square, Kruskal-Wallis and two-tailed Fisher exact tests were used as appropriate. The null hypothesis was rejected when probability values were less than 0.05. To detect a 30% difference with 80% power and 5% level of significance, it was estimated that 28 patients would be required in each group.
RESULTS
A total of 119 patients were studied. Each group consisted of 30 patients except for Group PO where one patient was excluded because of an unanticipated difficult intubation despite rescue with suxamethonium. The four groups were similar in age, weight, gender and haemodynamic measurements before induction of anaesthesia ( Table 2 ). The results between groups for ease of intubation, intubation score, jaw relaxation, ease of insertion of ETT, coughing on intubation and haemodynamic response was not affected by the dosage of propofol. The mean dose requirement for induction by propofol was higher in the two groups without alfentanil (P<0.005). Without alfentanil, the required propofol dose was found to be 3 mg/kg compared with 2.5 mg/kg in the alfentanil groups.
Of the 119 patients, attempts to intubate failed in six patients: five in Group PO and one in Group PA15 (Table 3 ). This represented 17% and 4% failure respectively. Tracheal intubation was successful in all patients in Groups PA30 and PS. Overall intubation conditions were similar between Groups PA15 and PS (P=0.112) ( Figure 1 ). Both alfentanil 30 µg/kg and suxamethonium 1.0 mg/kg provided similar overall intubating conditions (P=1), and had significantly larger number of "good" vs "moderate" and "poor" overall intubation conditions compared to alfentanil 15 µg/kg or saline control (P<0.01).
Jaw relaxation was similar in all groups (Figure 2a ). In relation to conditions for insertion of the endo-tracheal tube, propofol alone was unsatisfactory where there was vocal cord movement in about 50% of the patients (Figure 2b ). The addition of alfentanil 15 µg/kg did not significantly improve conditions for insertion of the endotracheal tube (P=0.09). Alfentanil 30 µg/kg significantly improved this further and produced conditions similar to that provided by suxamethonium (P=1.0). Concerning incidence of coughing ( Figure 2C ), suxamethonium was still superior (i.e. no cough) to alfentanil 30 µg/kg (P=0.041). Alfentanil 15 µg/kg or propofol alone were very unsatisfactory in this respect. Although alfentanil 30 µg/kg provided similar overall intubating conditions to suxamethonium, only 60% of patients who received alfentanil 30 µg/kg had a maximum intubation score of 6, indicating optimum intubating conditions, compared to 85% of patients who received suxamethonium (Table 4) . Mean arterial pressure (MAP) decreased significantly from baseline values in all groups after induction (P<0.00001) ( Figure 3 and Table 5 ). Propofol alone caused about a 10 mmHg reduction in the MAP. The addition of alfentanil reduced the MAP approximately by a further 10 mmHg, thereafter remaining fairly stable. Both dosages of alfentanil were equally effective in attenuating the pressor response to laryngoscopy and tracheal intubation (P<0.001). This reduction of blood pressure however did not require any additional fluid load or vasopressor therapy. Similarly, increases in heart rate associated with laryngoscopy and tracheal intubation were effectively attenuated in both the alfentanil groups (P<0.05) ( Figure 4 ). Patients in the suxamethonium group showed an increase in heart rate of up to 17% from baseline values.
Arterial oxygen desaturation did not occur in any of the patients, nor did we notice any apnoea nor chest wall rigidity after alfentanil.
DISCUSSION
Since its introduction into anaesthetic practice in 1951 15 , suxamethonium has remained the drug of choice for providing reliable conditions for rapid tracheal intubation during anaesthesia. It is not an 227 
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Anaesthesia and Intensive Care, Vol. 24, No. 2, April 1996 uncommon clinical dilemma for the anaesthetist to encounter situations where rapid tracheal intubation is required and where suxamethonium is absolutely contraindicated, such as in burns, denervation injuries, neuromuscular diseases, in chronic renal failure or even in patients suffering from cholinesterase deficiency. Nondepolarizing muscle relaxants either with high-dose 16 or the priming tech-nique [17] [18] [19] [20] are an alternative but are much slower in onset of action. The long duration of action of nondepolarizing muscle relaxants is a further disadvantage and would be hazardous should intubation fail. Rocuronium 21, 22 , which has shown promise in providing satisfactory rapid intubating conditions, has this same disadvantage. Furthermore, patients may be alarmed should they develop partial paralysis with the small, subparalysing priming dose of the nondepolarizing muscle relaxant. There is still the risk of aspiration of gastric contents during this period of partial paralysis before the airway is protected. On the contrary, the propofol-alfentanil induction sequence has the advantage that the apnoea which occurs could be reversed with the use of an opioid antagonist. In this study, two dosages of alfentanil were investigated. The lower 15 µg/kg dose was based on the dosing guidelines 23 when respiration is assisted during anaesthesia and surgery. Alfentanil at 30 µg/kg has been suggested as the optimum dose to effectively attenuate the hypertensive and tachycardic response to intubation without altering global indices of cardiac function 24 .
Unexpectedly, we found alfentanil at 15 µg/kg was no better than saline after propofol induction. Although the incidence of failed intubation was reduced from 17% with saline control to 4% with alfentanil 15 µg/kg, this is still clinically unacceptable in emergency rapid tracheal intubation situations. While overall intubating conditions were satisfactory 228 A. K. H. WONG, G. S. TEOH Anaesthesia and Intensive Care, Vol. 24, No. 2, April 1996 and intubation was successful in all patients who received alfentanil 30 µg/kg and propofol, more patients had optimum intubating conditions (i.e. score of 6) with suxamethonium. Perhaps by administering a higher dosage of alfentanil, intubating conditions may be better than those provided by suxamethonium. However, we felt that this would be undesirable because of the possibility of inducing a greater drop in blood pressure, or causing chest wall rigidity and even bradycardia. A 20% reduction in the mean arterial pressure produced by alfentanil 30 µg/kg and propofol would be undesirable in certain categories of patients. In such patients, "preloading" with 500-1000 ml of fluid may compensate for the reduction of systemic vascular resistance and consequently minimize the decrease in blood pressure. Anaesthesia induction time with propofol is highly dependent on the rate of injection 25, 26 . As such, propofol was given at a rate of about 200 mg/min. As loss of eyelash reflex is an inconsistent end-point for propofol induction 26 , we used loss of response to verbal command from the patient. Thus it was not surprising that the dose requirement for propofol was lower when alfentanil was also given. Even though the dose requirement for propofol induction appeared to be 2.5 mg/kg when alfentanil was used, it would seem prudent to remember that the population of patients in this study were healthy patients of ASA 1 and 2 physical status. A sensible approach would be to titrate induction against an acceptable end-point for all patients. Similarly, in ASA 3 and 4 patients, a lower rate of injection of propofol would be preferred, to minimize decreases in blood pressure 25 .
We believe that propofol and alfentanil 30 µg/kg provides an alternative to the standard rapid sequence induction regimen. Furthermore, propofol and alfentanil 30 µg/kg may prove to be extremely useful should suxamethonium be absolutely contraindicated on clinical grounds. Although such situations are uncommon, the availability of this technique lends confidence to our practice. With the additional ability of propofol and alfentanil 30 µg/kg to effectively obtund the haemodynamic response to laryngoscopy and tracheal intubation, this technique must be considered as an excellent alternative for rapid tracheal intubation.
